|
J Biol Chem, Vol. 273, Issue 37, 23812-23822, September 11, 1998
The Soluble -Glycerophosphate Oxidase from Enterococcus
casseliflavus
SEQUENCE HOMOLOGY WITH THE MEMBRANE-ASSOCIATED DEHYDROGENASE AND
KINETIC ANALYSIS OF THE RECOMBINANT ENZYME*
Derek
Parsonage,
James
Luba,
T. Conn
Mallett, and
Al
Claiborne
From the Department of Biochemistry, Wake Forest University Medical
Center, Winston-Salem, North Carolina 27157
 |
ABSTRACT |
The soluble flavoprotein -glycerophosphate
oxidase from Enterococcus casseliflavus catalyzes the
oxidation of a "non-activated" secondary alcohol, in contrast to
the flavin-dependent -hydroxy- and -amino acid
oxidases. Surprisingly, the -glycerophosphate oxidase sequence is
43% identical to that of the membrane-associated -glycerophosphate
dehydrogenase from Bacillus subtilis; only low levels of
identity (17-22%) result from comparisons with other FAD-dependent oxidases. The recombinant
-glycerophosphate oxidase is fully active and stabilizes a flavin
N(5)-sulfite adduct, but only small amounts of intermediate flavin
semiquinone are observed during reductive titrations. Direct
determination of the redox potential for the FAD/FADH2
couple yields a value of 118 mV; the protein environment raises the
flavin potential by 100 mV in order to provide for a productive
interaction with the reducing substrate. Steady-state kinetic analysis,
using the enzyme-monitored turnover method, indicates that a ping-pong
mechanism applies and also allows the determination of the
corresponding kinetic constants. In addition, stopped-flow studies of
the reductive half-reaction provide for the measurement of the
dissociation constant for the enzyme· -glycerophosphate complex and
the rate constant for reduction of the enzyme flavin. These and other
results demonstrate that this enzyme offers a very promising paradigm for examining the protein determinants for flavin reactivity and mechanism in the energy-yielding metabolism of
-glycerophosphate.
 |
INTRODUCTION |
-Glycerophosphate
( -GP)1 oxidase is a
soluble flavoprotein which catalyzes the oxidation of -GP DHAP
with concomitant reduction of O2 H2O2 (1, 2). In the heme- and
cytochrome-deficient enterococci (3), the enzyme plays a key role in
channeling glycerol into the glycolytic pathway. This
FAD-dependent oxidase can be compared with FAD-containing
-amino acid oxidases (e.g. D-amino acid
oxidase; Ref. 4) and FMN-dependent -hydroxy acid oxidases (e.g. lactate oxidase; Ref. 5), as well as with
those FAD-dependent oxidases which carry out the oxidations
of "non-activated" substrates (e.g. glucose oxidase;
Ref. 6). It is firmly established from studies of flavoprotein
active-site environments by Massey Ghisla Hemmerich and co-workers
(7-9) that, in general, flavoprotein oxidases give substantial
stabilization to the blue p-quinoid form of 8-mercaptoflavin
and the anionic benzoquinoid forms of other 6- and 8-substituted
mercapto- and hydroxyflavins; these proteins also stabilize flavin
N(5)-sulfite adducts as well as the anionic semiquinone and fully
reduced forms of natural FAD or FMN. All of these properties can be
ascribed to the general influence of a positive charge originating
either with a specific side chain or helical dipole in the vicinity of
the flavin N(1)-C(2)=O locus. In addition, the reaction leading to the
formation of the N(5)-sulfite adduct has mechanistic relevance (7, 8)
in that it parallels the nucleophilic attack of the substrate carbanion considered for the reductive half-reaction of, for example,
D-amino acid oxidase (10). We have shown that the active
site environment of -GP oxidase closely resembles those of other
flavoprotein oxidases; this enzyme also stabilizes the blue
p-quinoid form of 8-mercapto-FAD and the anionic forms of
natural FAD in both oxidized (pKa = 8.5 for N(3)-H)
and fully reduced states (1).
-GP oxidase catalyzes the FAD-dependent oxidation of an
alcohol, similar to the reactions of glucose oxidase, methanol oxidase, and cholesterol oxidase (11); the pKa for the C(2)-H of -GP is presumably ~40, reflecting the absence of electron withdrawing or "activating" substituents capable of stabilizing the
corresponding substrate carbanion. We have shown that reduction of
-GP oxidase by nitroethane anion is slow relative to the reduction of D-amino acid oxidase; this observation adds to the
conclusion that a carbanion mechanism is unlikely to apply for -GP
oxidase (1). And, while both radical and hydride transfer mechanisms have been discussed (11) for flavoprotein oxidases with
"non-activated" substrates such as -GP, we have shown that
-GP oxidase reconstituted with 5-deaza-FAD is reduced by -GP (1);
it appears that a hydride transfer mechanism similar to that employed
by the cytosolic, pyridine nucleotide-dependent -GP
dehydrogenase (12) is most consistent with the data available for
-GP oxidase. The first direct evidence supporting a hydride transfer
mechanism in a flavoprotein oxidase reaction came with the early
kinetic studies of glucose oxidase by Bright, Gibson, and co-workers
(13-15), and it appears likely that -GP oxidase and glucose oxidase
share similar mechanisms of substrate oxidation.
From the structural perspective, Mattevi et al. (4) have
concluded that glucose oxidase and cholesterol oxidase constitute a
subfamily of FAD-dependent oxidases distinct from that
represented by D-amino acid oxidase, and this
classification has been extended to suggest that other non-activated
alcohol oxidases such as methanol oxidase are structurally and
mechanistically related to the glucose oxidase/cholesterol oxidase
subfamily (16, 17). With these considerations in mind, we present the
primary structure of -GP oxidase along with an analysis of the
recombinant enzyme, including its redox properties and reactivity with
sulfite. The steady-state kinetic mechanism and the reductive
half-reaction have both been analyzed by stopped-flow techniques; in
combination these results demonstrate that the rate-limiting step in
catalysis is transfer of the hydride equivalent from -GP to the
enzyme flavin.
 |
EXPERIMENTAL PROCEDURES |
Materials and General
Methods--
Isopropyl-1-thio- -D-galactopyranoside was
purchased from 5 Prime 3 Prime, Inc., and agarose was from FMC
BioProducts. Both DL- -GP and the L-isomer
were purchased from Sigma, as were o-dianisidine·2HCl, horseradish peroxidase (Type VI), and streptomycin sulfate. Indigo carmine (indigo disulfonate) was also purchased from Sigma, and sodium
sulfite was from Fisher. All other chemicals, as purchased from sources
given previously (1, 18, 19), were of the best grades available.
Bacterial Strains--
Enterococcus casseliflavus
(ATCC 12755) and Escherichia coli XL1-Blue (Stratagene) were
maintained and cultured as described previously (20).
Streptococcus pneumoniae (ATCC 27336) was grown with shaking
at 37 °C in Brain Heart Infusion medium (Difco).
glpO Oligonucleotide Design and PCR Amplification--
A crude
lyophilized sample of E. casseliflavus -GP oxidase was
obtained from the Bio-Products Division of Eastman Kodak Co. and
purified essentially as described previously (1). The N-terminal sequence determined for the intact protein is:
Thr-Phe-Xxx-Gln-Lys-Asp-Arg-Lys-Glu-Thr-Ile-Gln. One nmol of enzyme was
then digested with lysyl endopeptidase (Wako BioProducts), and an
aliquot of the digest was chromatographed on a C8
reverse-phase high performance liquid chromatography column. Ten
peptide fractions were collected and submitted for sequence analysis;
one peptide (Gpo3) gave the amino acid sequence:
Thr-Tyr-Phe-Gly-Thr-Xxx-Asp-Thr-Asp-Tyr-Thr-Gly-Asp-Phe-Ala-His-Pro-Thr-Val-Thr-Gln-Glu-Asp-Val-Asp-Tyr-Leu-Leu-Thr-Ile-Val-Asn-Glu. Oligonucleotide primers were then designed from the -GP oxidase N-terminal (Gln4-Gln12) and Gpo3 peptide
(Asp13-Asp23) sequences as follows, using
enterococcal codon usage data (21),
Genomic DNA from E. casseliflavus was subjected to PCR
amplification using the gpo1 plus gpo3 primer
combination, resulting in a 0.9-kb product which was characterized
further by partial sequence analysis (20).
The glpO ( -GP oxidase) gene from S. pneumoniae
was amplified as two overlapping products of 2.4 and 1.8 kb. The 5'-end
of the S. pneumoniae glpO was amplified using the degenerate
glk1 primer (20) plus a glpO primer based on the
sequence Trp73-Ile80 reported by Pearce
et al. (22) for the Exp6 coding sequence from S. pneumoniae. The 3'-end of the pneumococcal glpO was
amplified using degenerate primers based on 1) the N-terminal E. casseliflavus -GP oxidase sequence
Gly26-Gly33 and 2) the sequence
Ala61-Thr68 reported by Saluja and Weiser (23)
for the S. pneumoniae glycerol uptake facilitator.
Cloning the glpO Gene from E. casseliflavus--
Chromosomal
DNAs were prepared from E. casseliflavus and S. pneumoniae by the method of Caparon and Scott (24). Southern blots
of E. casseliflavus genomic DNA digested separately with HindIII and with KpnI revealed single bands of
4.0 and 1.6 kb, respectively, when probed with the digoxigenin-labeled
glpO PCR product. Based on the results of these analyses,
genomic DNA was digested with HindIII, and fragments of 3-5
kb were size-selected following agarose gel electrophoresis. Analysis
of the glpK (glycerol kinase) locus immediately preceding
glpO (20) had indicated the presence of a ClaI
site approximately 300 bp upstream of the glpO start codon,
so the pool of 3-5 kb HindIII fragments was cut with
ClaI, and a subgenomic library was then generated in pBluescript from this pool. XL1-Blue recombinants were screened by
hybridization with the glpO probe. From approximately 200 recombinant colonies screened, 3 were found to give positive signals.
Restriction analysis of DNA isolated from one of these clones showed
that it had a 1.4-kb insert, and this recombinant was designated
pGLP01. From the restriction map of the glpKO PCR product
(20) and the size of the pGLP01 insert, we estimated that this
recombinant would lack at least 650 bp of the glpO coding
sequence, corresponding to the C-terminal 40% of the polypeptide.
Digestion of pGLP01 with PstI and HindIII gave a
650-bp product corresponding to the 3'-end of the insert; this fragment
was labeled and used as a probe in genomic Southern blots of DNA
digested with PstI in combination with each of several other
enzymes in order to identify fragments which would complement the
pGLP01 insert. In this manner a 1.7-kb PstI fragment was
identified in genomic digests; a subgenomic library was prepared in
pBluescript from size-selected 1-2-kb genomic PstI
fragments. This library was screened in XL1-Blue with the labeled
PstI/HindIII fragment, yielding pGPO6, with a 1.7-kb insert.
DNA Sequencing of glpO Clones--
The inserts from the two
E. casseliflavus glpO clones, pGLP01 and pGPO6, were
subcloned into the plasmid pMOB for transposon-facilitated sequencing
using TN1000 (20, 25). Overall, the entire glpO locus on the
two overlapping clones was sequenced on both strands. The two
overlapping PCR products corresponding to the S. pneumoniae glpO locus were gel-purified and submitted for automated analysis by the DNA Sequencing and Gene Analysis Facility, Wake Forest University Medical Center. Contig assemblies, GAP alignments, and data
base searches were carried out using the GCG suite of DNA analysis
programs (26), in addition to the Factura and AutoAssembler programs
(Perkin-Elmer).
Expression and Purification of Recombinant -GP
Oxidase--
For expression of the E. casseliflavus -GP
oxidase in E. coli, the vector used was a chloramphenicol
resistance conferring derivative of pBluescript II KS( ) (18).
This plasmid was prepared by ligating the 1.63-kb
HincII-AccI fragment from pACYC184 with the
1.95-kb BspHI fragment from pBluescript II KS( ) after both fragments had been made blunt-ended by treatment with T4 DNA polymerase and dNTPs. The EcoRI site within the cat gene was
removed as described by Parsonage et al. (18), and the
resultant plasmid was designated pOXO10. The sequence upstream of
glpO was replaced by a nearly identical copy (GAGGAG) of the
ribosome-binding site of the highly expressed gene 10 from
the T7 phage (27), using PCR. The template used was the chromosomal
clone pGLP01, and the primers were the T3 primer and the primer
gpo-rbs, which has the sequence:
5'-AAAACTCGAGGAGATATACATATGACCTTTTCTCAGAAAGATC-3'. A XhoI site, introduced for cloning, and the ATG start codon
within gpo-rbs are indicated in bold letters. The resulting
PCR product was digested with XhoI, at the site introduced
via the gpo-rbs primer, and PstI, at the site
within glpO, giving a 480-bp fragment which was cloned into
similarly cut pBluescript II SK(+). The entire insert was sequenced to
confirm that no spurious mutations had been introduced by
Taq polymerase. A ligation mixture was then set up to
include the PCR-generated XhoI-PstI fragment, the 1.38-kb
PstI-BglII fragment from pGPO6 containing the
3'-end of glpO, and XhoI- plus
BamHI-digested pBluescript II SK(+) to generate pGPO15. The
entire glpO gene, with the engineered ribosome-binding site,
was transferred to pOXO10 as a XhoI-SacI fragment
to create the expression plasmid pGPO16.
Expression of -GP oxidase was carried out under the control of the
pOXO10 lac promoter. XL1-Blue cells transformed with pGPO16 were grown at 30 °C in 10 2.8-liter Fernbach flasks, each containing 600 ml of LB medium, pH 7.4, plus 33 µg/ml chloramphenicol and 50 µM isopropyl-1-thio- -D-galactopyranoside.
After 26 h of growth, cells were harvested and washed with 50 mM potassium phosphate, pH 7.0, plus 0.6 mM
EDTA, and frozen at 70 °C. Cells were disrupted for enzyme
purification by passage through an SLM/Aminco French press. Cell debris
was removed by centrifugation and nucleic acids were precipitated with
2.5% (w/v) streptomycin sulfate. The 45% saturated ammonium sulfate
supernatant was dialyzed overnight against 0.1 M potassium
phosphate, pH 7.0, plus 0.1 M KCl and 0.6 mM
EDTA, and loaded onto a 25-ml Q-Sepharose Fast Flow column (Pharmacia
LKB Biotechnology, Inc.) equilibrated with the same buffer. -GP
oxidase was eluted with a 0.1 to 0.3 M KCl gradient in the
pH 7.0 phosphate buffer. Fractions with an
A280/A442 ratio of less
than 14 were pooled and dialyzed against 10 mM potassium phosphate, pH 7.0. Protein was applied to a 130-ml column of Macro-Prep Ceramic Hydroxyapatite (type I, 40 µm; Bio-Rad) equilibrated with the
dialysis buffer. The enzyme was eluted with a 10-200 mM
gradient of phosphate buffer, pH 7.0. Fractions with a
A280/A446 ratio of less
than 7, and which were homogeneous by SDS-PAGE, were pooled, concentrated, and buffer exchanged into 50 mM potassium
phosphate, pH 7.0, plus 0.6 mM EDTA by ultrafiltration.
Purified -GP oxidase was stored in aliquots at 20 °C.
Static Titrations--
Static titrations and spectral
measurements were performed using either a Hewlett-Packard Model 8451A
or 8452A single-beam diode-array spectrophotometer, as described
previously (19). E'0 for the -GP oxidase
FAD/FADH2 redox couple was determined by dithionite
titration (19) in the presence of the reference dye indigo disulfonate
(E'0 = 125 mV; Ref. 28), with benzyl viologen
present at low concentration to ensure rapid equilibration of reducing
equivalents.
Stopped-flow Kinetics--
All rapid-reaction analyses were
carried out with the Applied Photophysics DX.17MV stopped-flow
spectrophotometer, which includes the Applied Photophysics
photodiode-array detector as recently described (29). The reaction of
sulfite with -GP oxidase was measured at 446 nm; 28 µM
enzyme (final concentration) was reacted in 0.1 M potassium
phosphate, pH 7.0, plus 0.3 mM EDTA, under aerobic
conditions at 25 °C. Final sulfite concentrations
([HSO3 + SO32 ]) were 0.1, 0.5, 1, 4, and 8 mM; stock solutions were prepared in the same pH 7.0 phosphate buffer. The steady-state kinetic analysis for -GP oxidase
was carried out at pH 7.0, 5 °C, using the enzyme-monitored turnover
method as described by Gibson et al. (30). These
measurements were made with a final concentration of 9 µM
enzyme under [O2]-limited conditions ([O2] = 0.78 mM), where the dissolved [O2] in
buffer at 25 °C is taken as 0.26 mM under ambient
conditions (31). The range of [L- -GP]s used was 5-50
mM; kinetic data were acquired at 446 nm and were analyzed as recommended by Cornish-Bowden (32). This method was applied previously in the kinetic characterization of the recombinant NADH
peroxidase (18), where a detailed description is provided. The
anaerobic reduction of -GP oxidase by L- -GP was
investigated in both single wavelength (446 nm) and diode-array
detection modes. The stopped-flow system was prepared for anaerobic
work following a modified protocol which has recently been described
(29). The contents of the enzyme tonometer and the glass syringes
containing L- -GP were prepared for anaerobic work as
described previously (33); in addition, both enzyme and substrate
solutions contained the protocatechuate dioxygenase/protocatechuic acid
oxygen-scrubbing system (34). Enzyme (28.9 µM final
concentration) and -GP were mixed at 5 °C in the 0.1 M phosphate, pH 7.0 buffer; the range of
[L- -GP]s was 12.5-50 mM. Kinetic data
from both the sulfite reaction and the reductive half-reaction were
analyzed using the SX.18MV and Pro-Kineticist (Pro-K) packages from
Applied Photophysics, as described recently (29).
Protein Analyses--
Electrospray interface-mass spectrometry
(ESI-MS) and protein sequence analyses were provided by the Analytical
Chemistry and Protein Analysis Core Laboratories, Comprehensive Cancer
Center of Wake Forest University.
 |
RESULTS |
Nucleotide Sequence of the E. casseliflavus glpO Gene--
The
composite sequence derived from the two overlapping clones (pGLP01 and
pGPO6) includes 2531 bp which accounts for the entire glpO
coding sequence (1830 bp) as well as a partial open reading frame of
315 bp preceding glpO, which corresponds to the 3'-end of
the glpK gene encoding glycerol kinase (20). An intergenic region of only 3 bp separates the glpK stop codon from the
glpO start codon. A third coding sequence begins within the
3'-end of glpO, giving rise to a 387-bp ORF which is
interrupted by the end of the pGPO6 insert. The sequence of this third
overlapping ORF will be described in a separate article. Fig.
1 gives the 1862-bp sequence, including
the glpO gene and the ribosome-binding site (AGAAGG)
identified 16 bp upstream of the Met1 codon. On the basis
of the N-terminal protein sequence for -GP oxidase given previously
("Experimental Procedures") the ATG codon corresponding to the
start codon was recognized immediately, although the initiating Met is
removed post-translationally in E. casseliflavus. glpO
encodes a polypeptide of 609 amino acids with a calculated molecular
weight of 67,174 (including Met1), similar to the value of
65,000 determined previously by SDS-PAGE for the purified enzyme (1).
The amino acid composition is in good agreement with that determined
for the protein purified from E. casseliflavus (1), with the
significant exceptions being the branched-chain amino acids, which were
consistently under-represented in the chemical analysis (most likely
due to incomplete hydrolysis even at 96 h), and Ser, which was
overrepresented in the earlier report (36 versus 29 Ser/subunit). The -GP oxidase sequence also corroborates the absence
of Cys and the low Trp content. There is perfect agreement with the
N-terminal (Thr2-Gln13) and Gpo3 peptide
sequences given earlier; the latter corresponds to the sequence
Thr295-Glu327 in -GP oxidase.

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 1.
DNA sequence of the E. casseliflavus
glpO gene. The deduced protein sequence is also given. The
positions of PstI, HindIII, and BglII
restriction sites are indicated, as are the sequences corresponding to
a putative ribosome-binding site (RBS) and the
glpO initiation codon.
|
|
-GP Oxidase Is Homologous with the Membrane-associated -GP
Dehydrogenases--
Sequence and crystallographic analyses indicate
that there are two classes of FAD-dependent oxidases,
represented by D-amino acid oxidase (4) and by glucose
oxidase (6) and cholesterol oxidase (16). Frederick et al.
(35) initially identified three specific regions of 30-40 residues
each which showed identity levels of ~50% between glucose oxidase
and methanol oxidase; Vrielink and co-workers (16, 17) have extended
the comparison for these two enzymes to include cholesterol oxidase,
based on a structural alignment. Initially we anticipated that the
-GP oxidase sequence would compare favorably with these proteins.
However, a TFASTA search of the GenEMBL Data Bank failed to identify
any other FAD-dependent oxidase sequences as related to
-GP oxidase; individual GAP alignments with glucose oxidase,
cholesterol oxidase, and D-amino acid oxidase gave identity
levels of 17, 17, and 22%, respectively. In contrast, high scores were
observed, surprisingly, for the membrane-associated flavoprotein -GP
dehydrogenases from several bacterial and mitochondrial sources. GAP
alignments reveal 43% identity between -GP oxidase and the -GP
dehydrogenase from the Gram-positive Bacillus subtilis (36)
and 30-32% for the -GP dehydrogenases from the Gram-negative E. coli (37) and Pseudomonas aeruginosa (38). The
CLUSTAL (39) alignment given in Fig. 2
for -GP oxidase and the three bacterial -GP dehydrogenases
indicates that conserved regions are generally distributed over the
entire oxidase sequence, with the major exception being a 52-residue
insert following Gly355 (relative to the B. subtilis sequence) which has no counterpart in the dehydrogenases.
Also indicated in Fig. 2 is the -GP oxidase segment
Asp21-Glu49, which satisfies eight of the 11 requirements defined by Wierenga et al. (40) for the
ADP-binding fold involved in FAD binding, and two short segments
(Ser342-Ile350 and
Gly430-Ile433) which have been suggested by
Austin and Larson (37) to be involved in -GP binding with the
E. coli dehydrogenase. Individual GAP alignments indicate
identity levels of 33-34% for the -GP oxidase and the
mitochondrial dehydrogenases from yeast (41), rat (42), and human (43)
sources.

View larger version (79K):
[in this window]
[in a new window]
|
Fig. 2.
CLUSTAL alignment comparing E. casseliflavus -GP oxidase with the -GP dehydrogenases from
E. coli, P. aeruginosa, and B. subtilis. Boxes represent residues conserved in
all four sequences, and segments corresponding to the FAD-binding and
putative " -GP-binding" sites are indicated as well.
|
|
The TFASTA search with the E. casseliflavus -GP oxidase
also identified the S. pneumoniae exp6 gene, a partial
coding sequence described by Pearce et al. (22) in their
genetic analysis of exported proteins in pneumococci. Sequence
comparisons revealed an optimal 80-residue overlap between Exp6 and the
B. subtilis -GP dehydrogenase, with 68% identity. In a
subsequent study, Saluja and Weiser (23) cloned a genetic locus from
S. pneumoniae which is associated with the expression of
colony opacity, and this locus also contains a partial ORF (ORF1)
homologous to the B. subtilis dehydrogenase. While both the
S. pneumoniae Exp6 and ORF1 sequences compare favorably with
the E. casseliflavus -GP oxidase sequence,
these analyses suggested that a single base was missing after position
285 of the published ORF1 sequence. We therefore cloned the gene
encoding the S. pneumoniae -GP oxidase homolog by PCR, as
described under "Experimental Procedures," and the translated
full-length sequence is given in Fig. 3.
The pneumococcal sequence is 61% identical to the enterococcal -GP oxidase and includes both the Exp6 and ORF1 partial coding sequences; the full-length pneumococcal glpO sequence also includes an
additional guanine base after position 285 of the ORF1 sequence, which
changes the translated sequence for the published segment corresponding to amino acid residues 96-154 (23). Fig. 3 also gives the translated sequence for the -GP oxidase homolog identified in the
Streptococcus pyogenes genome sequence data base
(44); the two streptococcal oxidase sequences are 76% identical.
Recently Erlandson and Batt (45) have reported the sequence of a
partial ORF from Lactococcus lactis subsp. lactis
which is 42% identical to the B. subtilis -GP
dehydrogenase. The lactococcal ORF corresponds to the N-terminal 250 residues of the enterococcal -GP oxidase, with 61% identity.

View larger version (81K):
[in this window]
[in a new window]
|
Fig. 3.
CLUSTAL alignment comparing the -GP
oxidase sequences from E. casseliflavus, S. pyogenes, and S. pneumoniae.
|
|
Catalytic, Spectral, and Redox Properties of Recombinant -GP
Oxidase--
Since the E. casseliflavus glpO locus was
cloned in two stages from two subgenomic libraries, we first
reconstructed the intact coding sequence as described under
"Experimental Procedures." Under standard T7 expression protocols
(18), however, the pGPO15 construct gave only modest levels of -GP
oxidase protein (Fig. 4, lane
2). By using a different expression protocol with the pGPO16
plasmid ("Experimental Procedures"), which contains the glpO gene under control of the lac promoter, up
to 11% of the soluble protein in recombinant extracts was shown to be
fully active -GP oxidase. This result is corroborated in the
SDS-PAGE analysis given in Fig. 4 (lane 4). The recombinant
-GP oxidase was purified from 6 liters of XL1-Blue(pGPO16) cultures;
up to 100 mg of the pure, soluble enzyme resulted with an average
specific activity of 80.5 units/mg. N-terminal sequence analysis of the recombinant enzyme indicates that the initiating Met is also removed in
E. coli, resulting in a calculated subunit m of
67,085 Da. Electrospray mass spectrometric analysis gives
m = 67,082 Da, in excellent agreement. The consistently
higher specific activity for the recombinant enzyme is in agreement
with the lower A280/A446 ratio of 6.1-6.4 (versus 7.0 for the enzyme from E. casseliflavus; specific activity = 62 units/mg). The visible
absorption spectrum of the purified recombinant enzyme (Fig.
5) is identical to that reported
originally for the protein purified from E. casseliflavus. In the earlier report (1) we also described an intense blue fluorescence which developed on storing the pure enzyme at 20 °C for a few weeks. The fluorescent species was not identified, however, and the recombinant protein exhibits no such blue fluorescence, even
after storage at 20 °C for up to 21/2 months. Analysis of the very weak flavin fluorescence indicates that the recombinant enzyme
is only 3% as fluorescent as free FAD at the same concentration.

View larger version (112K):
[in this window]
[in a new window]
|
Fig. 4.
SDS-PAGE analysis of -GP
oxidase-expressing clones and the purified recombinant enzyme. A
10% SDS-polyacrylamide gel was run with samples treated as described
previously (18). Lanes 1-4 contain crude extracts of
E. coli JM109DE3(pBluescript), JM109DE3(pGPO15),
XL1-Blue(pOXO10), and XL1-Blue(pGPO16). Lane 5 contains 1 µg of the recombinant enzyme, purified as described in the text.
Lane M contains low range protein standards (Bio-Rad); the
corresponding molecular masses (in kDa) are indicated.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
Sulfite reaction with recombinant -GP
oxidase. A, the enzyme (23 µM, in 50 mM potassium phosphate, pH 6.8, plus 0.6 mM
EDTA) was titrated with sodium sulfite solutions of 0.1 and 1.0 M. Spectra shown, in order of decreasing absorbance at 446 nm, correspond to the addition of 0 ( ), 0.24 mM (- -),
0.65 mM (-··-), 1.5 mM (- -), and
23.9 mM ( ) total sulfite
(HSO3 + SO32 ). B, the enzyme (28 µM final concentration) was reacted in the stopped-flow
spectrophotometer at pH 7.0, 25 °C, with sulfite; the range of
[HSO3 + SO32 ]s was 0.1-8 mM, as
indicated under "Experimental Procedures."
|
|
In parallel with their fundamentally different reactivities toward
oxygen, flavoprotein oxidases and dehydrogenases also offer striking
contrasts in their reactivities with sulfite (46). All oxidases
stabilize flavin N(5)-sulfite adducts, but no sulfite reaction is
observed with the dehydrogenases. Given the clear homology between
-GP oxidase and the -GP dehydrogenases, how does the sulfite
reactivity of the oxidase compare with that of other flavoprotein
oxidases? As also shown in Fig. 5, titration of the recombinant oxidase
with sulfite does lead to progressive bleaching of the oxidized flavin
absorbance, attributed to the formation of a flavin N(5)-sulfite adduct
with Kd(HSO3 + SO32 ) of 0.81 mM at
25 °C. Still, completion of the absorbance changes on each addition
was only observed after 10-12 min, indicating a relatively slow
sulfite reaction. In order to extend this observation, and in order to
confirm the Kd value independently, the kinetics of
the sulfite reaction with -GP oxidase were studied by stopped-flow
spectrophotometry at pH 7.0, 25 °C. These results are also given in
Fig. 5 and yield a second-order rate constant of 11.5 M 1 s 1 for the reversible
reaction; the y axis intercept from the direct plot of
kobs versus
[HSO3 + SO32 ] yields
koff = 0.01 s 1. Together these
values give Kd = 0.87 mM for the -GP oxidase sulfite complex, in very good agreement with the determination from the static titration. These values can also be compared with kon = 6.2 M 1
s 1 and 66 M 1 s 1,
respectively, for the sulfite reactions of cholesterol oxidase from
Brevibacterium sterolicum (Kd = 0.14 mM at pH 7.5, 25 °C; Ref. 47) and glucose oxidase
(Kd = 0.11 mM at pH 5.6, 25 °C; Ref.
35) but contrast sharply with kon = 1.5 × 105 M 1 s 1 for
lactate oxidase (Kd = 0.5 µM at pH
7.0, 25 °C; Ref. 5). While the formation of the sulfite adduct in
each case is taken to reflect the presence of a positively charged
locus of the respective protein which interacts with the pyrimidine ring of the flavin (46, 48), there is a substantial difference in the
free energies of activation ( G ) of 4.6-6.0
kcal/mol favoring the reaction with lactate oxidase over those with
-GP oxidase, glucose oxidase, and cholesterol oxidase.
A second general feature of flavoprotein oxidases, which has been taken
as a hallmark for those oxidases operating via carbanion mechanisms
(8), involves stabilization of the red anionic flavin radical on
one-electron reduction. Fig. 6 gives the
spectral courses for dithionite titrations of the recombinant -GP
oxidase at pH 7.0 (phosphate buffer) and pH 9.0 (Tris sulfate buffer).
At pH 7.0, the titration proceeds in two distinct phases; the first phase is characterized by isosbestic points at 327, 404, and 495 nm and
leads to the formation of a mixture of anionic and neutral semiquinones, as evidenced by increases in absorbance at 370 and 600 nm, respectively. Absorbance changes plotted versus
equivalents of dithionite per FAD are linear at 362, 446, and 580 nm
over the range of 0-0.5 mol of dithionite/FAD. Using the value of
610 = 3,700-3,800 M 1
cm 1 as determined for the blue semiquinone of glucose
oxidase (49), we can estimate that about 17% neutral radical is
present at ~0.8 mol of dithionite/FAD in the -GP oxidase
titration. Similarly, since  366 ~ 5,200 M 1 cm 1 for conversion of
oxidized glucose oxidase to the red semiquinone form (49), we can
estimate that perhaps 30% of the anionic -GP oxidase radical is
present in the mixture. The second phase of the titration at pH 7.0 leads to full reduction of the semiquinone and residual oxidized enzyme
forms; the overall titration requires 1.5-1.6 equivalents of
dithionite/FAD. This stoichiometry is identical to that reported
earlier (1) for the enzyme purified from E. casseliflavus.
It is also important to point out that under our experimental
conditions at pH 7.0, complications could have potentially arisen due
to the formation of the N(5)-sulfite complex, as documented in Fig. 5.
However, when the dithionite-reduced enzyme at pH 7.0 (Fig. 6) was
opened to air, 95% of the original oxidized enzyme spectrum returned
rapidly, indicating that a maximum of 5% of -GP oxidase could
possibly have been present in the form of the sulfite complex during
the reductive titration.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 6.
Anaerobic dithionite titrations of
recombinant -GP oxidase. A, the enzyme (34.5 µM, in 0.85 ml of 50 mM potassium phosphate,
pH 7.0, plus 0.6 mM EDTA) was titrated with a 2.3 mM solution of dithionite. Spectra shown, in order of
decreasing absorbance at 446 nm, correspond to the addition of 0 ( ),
0.21 (- -), 0.42 (-·-), 0.78 (···), and 1.71 ( )
equivalents of dithionite/FAD. B, the enzyme (36.6 µM, in 0.8 ml of 50 mM Tris sulfate, pH 9.0, plus 0.6 mM EDTA) was titrated with a 2.4 mM
solution of dithionite. Spectra shown, in order of decreasing
absorbance at 448 nm, correspond to the addition of 0 ( ), 0.1 (···), 0.32 (-·-), 0.54 (- -), 0.86 (-···-), and
1.62 ( ) equivalents of dithionite/FAD.
|
|
When the dithionite titration was repeated at pH 5.9 (data not shown)
in 0.1 M phosphate, 0.025 M MES buffer no
anionic semiquinone was observed, and the neutral species only
accounted for about 12% of the total enzyme at 0.7 equivalents of
dithionite/FAD. The spectral course of the pH 9.0 titration given in
Fig. 6 is also indicative of a small extent of semiquinone
stabilization during reduction of the recombinant enzyme. In this case,
however, there is essentially no intermediate species with absorbance
beyond 510 nm. Initially, there are isosbestic points at 357 and 407 nm, indicative of some anionic radical accumulation, and at 320 and 509 nm. After addition of only 0.1 equivalents of dithionite/FAD, however,
the isosbestic behavior in the 357-407 nm region changes such that
further absorbance increases are not observed, reflecting the small
extent of radical stabilization. The absence of long-wavelength absorbance is consistent with the presence of anionic semiquinone, in
contrast to the pH 5.9 titration described above. Complete reduction
requires 1.2 equivalents of dithionite/FAD.
The redox potential (E'0) for the -GP/DHAP
couple is 190 mV (28), and we initially attempted to determine the
-GP oxidase FAD/FADH2 redox potential by dithionite
titration in the presence of the reference dye
anthraquinone-2,6-disulfonate (E'0 = 184 mV;
Ref. 28). Enzyme reduction in this case was essentially complete before
significant dye reduction was observed, however, indicating that the
enzyme potential was much higher than 184 mV. This experiment was
then repeated in the presence of indigo disulfonate
(E'0 = 125 mV; Ref. 28). Reduction of the
reference dye was monitored at 610 nm, where the enzyme has no
absorbance. Enzyme reduction was followed at 452 nm, an isosbestic
wavelength for oxidized and reduced forms of the dye. By calculating
the concentrations of oxidized and reduced dye and enzyme at each titration point, the midpoint potential can be determined from the
Nernst equation, given the known potential of the reference dye and the
ratio of the concentrations of oxidized and reduced dye at the midpoint
of enzyme reduction (50, 51). Following this procedure a redox
potential of 118 mV was determined for the FAD of recombinant -GP
oxidase; the plot of log
[E-FAD]/[E-FADH2] versus log [dyeox]/[dyered] has
a slope of 0.85.
Enzyme-monitored Turnover--
The enzyme-monitored turnover
method (30) was applied in order to determine the steady-state kinetic
mechanism for recombinant -GP oxidase and the associated kinetic
parameters. The stopped-flow traces given in Fig.
7 represent enzyme absorbance at 446 nm
as 9 µM oxidase is reacted at 5 °C in 0.1 M phosphate, pH 7.0, plus 0.6 mM EDTA with 0.78 mM O2 and varying concentrations of
L- -GP (5-50 mM). Immediately after mixing,
a steady state is established as determined by the relative rates of
enzyme reduction and oxidation (30, 52); even at 50 mM
L- -GP it appears that kreduction < koxidation at steady state. The steady state
persists until nearly all O2 is consumed, and the enzyme is
rapidly reduced at this point. Analysis of these traces as described by
Gibson et al. (30) gives rise to the plots of
[O2]/v versus [O2] shown in Fig.
8; as discussed by Cornish-Bowden (32),
the observed intersection of these lines representing fixed
concentrations of L- -GP on the y axis is
consistent with a ping-pong mechanism. A secondary plot of
[L- -GP]/Vapp versus
[L- -GP] gives Vmax and Km(L- -GP); at pH 7.0, 5 °C,
Km(L- -GP) = 24 mM,
Km(O2) = 35 µM, and
kcat = 37 s 1.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 7.
Enzyme-monitored turnover of -GP
oxidase. Enzyme (9 µM after mixing) in
air-equilibrated 0.1 M phosphate, pH 7.0, plus 0.6 mM EDTA, was mixed at 5 °C with different concentrations
of L- -GP which had been equilibrated with 100%
O2 in the same buffer. Final [L- -GP]s are
given, and the reactions were followed at 446 nm.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 8.
Kinetic analysis of enzyme-monitored turnover
experiments. A, primary plot of
[O2]/v (units of seconds) versus
[O2]; plots shown correspond to fixed
[L- -GP]s of 5 ( ), 10 ( ), 15 ( ), 25 ( ), and
50 ( ) mM. B, secondary plot of
[L- -GP]/Vapp (units of seconds)
versus [L- -GP]. Steady-state turnover
numbers were determined as described by Gibson et al. (30),
and kinetic parameters were determined as described in the text.
|
|
Reductive Half-reaction with L- -GP--
In order to
determine the kinetic mechanism for reduction of -GP oxidase by
substrate, the reaction was examined under anaerobic conditions at a
series of [L- -GP]s. Stopped-flow diode array analysis
at 12.5 mM L- -GP failed to provide evidence
for any spectral intermediates in the reaction, and direct reduction
was observed over the wavelength range 320-500 nm. No charge transfer species was detected over the wavelength range 400-1000 nm, as might
be expected for a reduced -GP oxidase·DHAP complex (5). When
analyzed in single-wavelength mode at 446 nm, however, reaction traces
were clearly biphasic; the faster phase accounted for 65% of the total
A446 at 12.5 mM L- -GP, but this increased
to 87% of the total A at 50 mM substrate (Fig.
9). Over this [L- -GP] range the rate constant for the slow phase was essentially unchanged (3.6 s 1 to 5.4 s 1 at 5 °C); this rate
constant is also significantly lower than the turnover number of 37 s 1. In contrast, when the values for
kfast are analyzed versus
[L- -GP] in a double-reciprocal plot (53), these data
are consistent with the following two-step mechanism for enzyme
reduction,
|
(Eq. 1)
|
where Kd(L- -GP) = 25 mM and kred = 48 s 1.
These values are in very good agreement with
Km(L- -GP) = 24 mM and
kcat = 37 s 1, respectively, as
determined above.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 9.
Kinetic analysis of the reduction of -GP
oxidase by L- -GP. A, enzyme (28.9 µM final concentration) was reacted with substrate in the
stopped-flow spectrophotometer under anaerobic conditions at pH 7.0, 5 °C, as described under "Experimental Procedures." Final
[L- -GP]s were 12.5, 17, 24, and 50 mM.
B, double-reciprocal plot of the observed first-order rate
constant for the fast phase of reduction (kfast)
as a function of [L- -GP]. This analysis yields
kred = 48 s 1 and
Kd(L- -GP) = 25 mM, as described in
the text.
|
|
 |
DISCUSSION |
The proteins involved in glycerol uptake and catabolism in the
Gram-positive Enterococcus represent a system for salvaging the glycerol moiety derived from the breakdown of phospholipids and
triglycerides (54); glycerol kinase and the -GP oxidase act in
concert to catalyze the net ATP-dependent conversion of glycerol to DHAP (20, 55). O2 is reduced to
H2O2 in the process, and the DHAP produced
enters the glycolytic pathway. Functionally -GP oxidase is similar
to the membrane-associated -GP dehydrogenases; in the latter case
additional ATP is produced through oxidative phosphorylation as
electrons are transferred from the reduced dehydrogenase to
O2, via the respiratory chain (56). The enterococci lack
the ability to synthesize heme and thus lack the respiratory cytochromes (3); the soluble -GP oxidase therefore allows for the
aerobic growth of these organisms when glycerol is the sole carbon and
energy source. The present work shows that the glpK and
glpO genes in E. casseliflavus are very tightly
linked as in an operon, which would allow for coordinate
transcriptional regulation of these genes in the presence of different
carbon sources. The capacity for aerobic conversion of glycerol to
lactate is one of the distinguishing metabolic features of
Enterococcus, when compared with the related genera
Streptococcus and Lactococcus (57). Although
S. pneumoniae is capable of slow acid production from
glycerol under aerobic conditions, this organism has complex growth
requirements and cannot grow with glycerol as its sole carbon and
energy source (23). Similarly, the lactococci have not been reported to
metabolize glycerol, either as a sole or cofermentable carbon source
(45). This work demonstrates that S. pneumoniae, S. pyogenes, and L. lactis all contain -GP oxidase homologs; in the former case the presence of the glpO (and
other glp) gene products provides the enzymological basis
for the slow acid production observed from glycerol. Furthermore,
Saluja and Weiser (23) have shown that the 2-kb colonial opacity locus from S. pneumoniae overlaps the glp gene cluster,
but there is no evidence linking these genes directly with the opacity
phenotype. Given the inability of either S. pyogenes or
L. lactis to produce acid from glycerol, the significance
and/or function of the glp genes in these organisms is at
present unknown.
The primary structure of -GP oxidase, apart from the N-terminal
FAD-binding region, is distinct from those of other
FAD-dependent oxidases. It should be emphasized, however,
that the cholesterol oxidase and glucose oxidase sequences exhibit only
21% identity; yet these proteins clearly show structural homology
(17). Nonetheless, on the basis of sequence analyses alone it is not
possible to make deductions regarding specific residues and their
catalytic roles in -GP oxidase. More significant at this point is
the striking homology between the oxidase and the membrane-associated
-GP dehydrogenases; this observation suggests that both genes
originally diverged from a common ancestor, perhaps in coordination
with the advent of cytochrome biosynthesis during the evolution of the
prokaryotes. Primarily because of the requirement for detergent and/or
phospholipid in the respective preparations, and in some cases the very
limited amounts of pure enzyme available, only a few kinetic and redox
properties have been described for the membrane-associated
dehydrogenases (56, 58, 59). In the absence of detailed structural
information, we can identify the   supersecondary structural
elements involved in FAD binding (40), and two of the postulated
" -GP-binding" segments (37) can also be identified by comparing
-GP dehydrogenase and oxidase sequences. One particular region which
is strongly conserved in the -GP oxidase and the six known -GP
dehydrogenases that we have analyzed corresponds to
Thr57-Leu72 in the oxidase; 11 of the 16 residues are absolutely conserved, but their functional significance is
unknown. It is also tempting to speculate that the 52-residue insert
(Ser356-Val407) that distinguishes -GP
oxidase from the dehydrogenases may contribute to the soluble
versus membrane-associated properties of the two enzymes. It
is important to note that in at least one other case, a
membrane-associated flavoprotein dehydrogenase has been identified as a
homolog of a soluble oxidase, as in the present case. Mandelate
dehydrogenase is therefore closely related to the
FMN-dependent -hydroxy acid oxidases, and Mitra et
al. (60) have demonstrated that a 50-residue segment in the middle
of the protein sequence accounts for the tight membrane association of the dehydrogenase. In comparing -GP oxidase with the homologous -GP dehydrogenases, however, it is the soluble protein which exhibits the extra internal segment, unlike its counterparts among the
membrane-associated enzymes. Adding further to the difficulty in
clarifying the factors responsible for membrane association with the
-GP dehydrogenases is the fact that, although the E. coli
enzyme has been described as an integral membrane protein (58),
hydropathy plots indicate that the polypeptide is sufficiently hydrophilic to exist as a soluble protein (37). The possibility of
membrane-anchoring subunit(s) interacting with the E. coli dehydrogenase has also been considered.
By applying enzyme-monitored turnover analysis (30) under
[O2]-limited conditions, we have shown that the
recombinant -GP oxidase follows a ping-pong kinetic
mechanism,
|
(Eq. 2)
|
This scheme is similar to those which have been shown to apply for
glucose oxidase, with 2-deoxyglucose as substrate (30), and for lactate
oxidase (5); as given, this kinetic pathway differs from the classical
ping-pong mechanism in the absence of a Michaelis complex between
E-FADH2 and O2. As derived for lactate oxidase (5), the corresponding kinetic constants are as
follows,
|
(Eq. 3)
|
Our analysis of the reductive half-reaction requires that
k2 k3 and that
k4 = 0 (53); the latter condition is also
supported experimentally by the fact that no reoxidation is observed
when 10 mM DHAP is mixed anaerobically with the reduced
enzyme (1). In addition the linear plots of [O2]/v
versus [O2] from the turnover analysis, as [DHAP]
approaches 0.7-0.8 mM, confirm that this product binds
very weakly, if at all. Furthermore, the reduction kinetics indicate
that the rate constant for DHAP release is much greater than the rate
constant for reduction (i.e. k5 k3). Under these conditions the steady-state
data yield,
|
(Eq. 4)
|
The numbers in parentheses represent the values calculated from
the corresponding rate constants. Although we have not directly determined k7, the rate constant for reoxidation
of reduced enzyme, the
kcat/Km(O2)
value of 1.1 × 106 M 1
s 1 at pH 7.0, 5 °C, does provide a lower limit and
this value is comparable to the second-order rate constants of 1.7 × 106 M 1 s 1 and
1.9 × 106 M 1
s 1 determined for the oxygen reactions of reduced glucose
oxidase (pH 5.6, 25 °C; Ref. 30) and lactate oxidase (pH 7.0, 25 °C; Ref. 5). With this in mind, there is very good agreement
between the experimentally determined and calculated values for these kinetic constants, further supporting the -GP oxidase mechanism presented above.
Our analysis of the reductive half-reaction with L- -GP
also revealed a second, slower phase in the A446
traces which was independent of [L- -GP], with
kslow = 3.6-5.4 s 1 at 5 °C.
Clearly kslow kcat = 37 s 1, and no comparable behavior was observed in the
steady-state analysis. Although not tested rigorously, we presently
interpret this result to indicate that the resting oxidized enzyme
exists in two states which are distinct in their abilities to bind
-GP productively for reduction (53),
|
(Eq. 5)
|
where reduction of E-FAD* is limited by
k10 = 3.6-5.4 s 1. The ratio of
the amplitudes ( A446) corresponding to
kfast and kslow (=k10) at saturating [L- -GP]
should equal k10/k11; at
50 mM substrate this gives
k10/k11 = 6.7.
The clear homology between -GP oxidase and the dehydrogenases raises
an interesting question regarding the active site environment of the
oxidase, since flavoprotein oxidases and dehydrogenases have
historically been contrasted on the basis of their differences rather
than compared in terms of their similarities. The reduced -GP
oxidase reacts rapidly with oxygen; we have also shown in this work
that the recombinant enzyme stabilizes the flavin N(5)-sulfite adduct
but does not provide for strong stabilization of the anionic semiquinone. With regard to the latter property it should be pointed out that although glucose oxidase yields a maximum of 90% anionic semiquinone during dithionite titration at pH 9.3, determination of the
midpoint potentials for the two one-electron transfers indicated that
kinetic factors account for a substantial component of the observed
radical stabilization (61). At pH 5.3, where kcat is maximal with glucose oxidase, there is
essentially no separation in the corresponding midpoint potentials.
Recently Gadda et al. (47) have reported only a modest
extent of kinetic stabilization for the anionic semiquinone of
cholesterol oxidase (Streptomyces hygroscopicus) on
photoreduction. Given the relatively weak semiquinone stabilization
observed with -GP oxidase, it appears that these three enzymes are
designed to oppose thermodynamic stabilization of the respective flavin
radicals and thus favor simultaneous two-electron transfer
mechanisms.
-GP oxidase and glucose oxidase stabilize the respective flavin
N(5)-sulfite adducts, although the corresponding
G values for sulfite addition at 25 °C
are 4.6-5.6 kcal/mol more positive than that for lactate oxidase (5,
35). -GP oxidase and glucose oxidase also stabilize the anionic
p-quinoid form of 8-mercapto-FAD, and in general the
properties of -GP oxidase contribute to a view of the active-site
environment in which the flavin N(1)-C(2)=O locus is strongly
influenced by either a positively charged side chain or helix dipole,
as is also the case for D-amino acid oxidase and other
flavoprotein oxidases (7). In addition, the present work demonstrates
that the -GP oxidase apoprotein raises the redox potential of the
bound FAD/FADH2 couple by 100 mV relative to the free
coenzyme ( 118 mV versus 219 mV; Ref. 28); this effect is
necessary in order to accommodate the redox potential of 190 mV for
the -GP/DHAP couple and may involve some of the same structural
factors which, for example, facilitate adduct formation with sulfite
(62). As has been stated (8), one of the hallmarks of those
flavoenzymes operating via carbanion mechanisms is the ability to form
a flavin N(5)-sulfite adduct; mechanistic parallels have been drawn
between the nucleophilic addition of sulfite to the flavin
N(5)-position and the postulated attack of a substrate carbanion
(e.g. with D-amino acid oxidase; Ref. 11) in the
catalytic process of flavin reduction. While the mechanisms of flavin
reduction for D-amino acid oxidase and lactate oxidase are
presently the subjects of intensive experimental study (63-66), it is
nonetheless clear that -GP oxidase and glucose oxidase, both of
which operate via hydride transfer mechanisms, also stabilize sulfite
adducts. To our knowledge the point has not been emphasized that the
reaction sequence leading to the nucleophilic addition of sulfite to
the flavin N(5)-position also nicely parallels the addition of a
hydride ion (H: ) to the -GP oxidase flavin (Scheme
1).
The positive charge contributed by the apoprotein allows the
stabilization of anionic FAD derivatives (e.g. N(1)- and
N(3)-anionic forms of FADH2 and FAD, respectively,
N(5)-sulfite complex, and anionic p-quinoid form of
8-mercapto-FAD) by the enzyme; the active site environment also
provides for both a 100 mV increase in the bound FAD redox potential
and the facile addition of the hydride ion to the flavin N(5)-position.
Given the homology between -GP oxidase and the membrane-associated
-GP dehydrogenases, our present deductions regarding the structural
and mechanistic parameters for -GP oxidation should also prove
useful in analyses of this aspect of membrane-associated electron
transport in both bacterial and mitochondrial systems.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM-35394.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequences for the E. casseliflavus and S. pneumoniae -glycerophosphate oxidase genes have been deposited in the GenBank data base under GenBank accession numbers U57498 and
U94770.
To whom correspondence should be addressed: Dept. of Biochemistry,
Wake Forest University Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. Tel.: 336-716-3914; Fax: 336-716-7671; URL:
http://invader.bgsm.wfu.edu/.
The abbreviations used are:
-GP, -glycerophosphate; DHAP, dihydroxyacetone phosphate; PCR, polymerase
chain reaction; LB, Luria-Bertani broth; PAGE, polyacrylamide gel
electrophoresis; E'0, midpoint
oxidation-reduction potential at pH 7.0ESI-MS, electrospray interface
mass spectrometryORF, open reading frameMES, morpholinoethanesulfonic acidbp, base pair(s)kb, kilobase
pair(s).
 |
REFERENCES |
-
Claiborne, A.
(1986)
J. Biol. Chem.
261,
14398-14407[Abstract/Free Full Text]
-
Esders, T. W.,
and Michrina, C. A.
(1979)
J. Biol. Chem.
254,
2710-2715[Abstract/Free Full Text]
-
Dolin, M. I.
(1961)
in
The Bacteria (Gunsalus, I. C., and Stanier, R. Y., eds), Vol. II, pp. 425-460, Academic Press, New York
-
Mattevi, A.,
Vanoni, M. A.,
Todone, F.,
Rizzi, M.,
Teplyakov, A.,
Coda, A.,
Bolognesi, M.,
and Curti, B.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
7496-7501[Abstract/Free Full Text]
-
Maeda-Yorita, K.,
Aki, K.,
Sagai, H.,
Misaki, H.,
and Massey, V.
(1995)
Biochimie (Paris)
77,
631-642[Medline]
[Order article via Infotrieve]
-
Hecht, H. J.,
Kalisz, H. M.,
Hendle, J.,
Schmid, R. D.,
and Schomburg, D.
(1993)
J. Mol. Biol.
229,
153-172[CrossRef][Medline]
[Order article via Infotrieve]
-
Massey, V.,
Ghisla, S.,
and Moore, E. G.
(1979)
J. Biol. Chem.
254,
9640-9650[Abstract/Free Full Text]
-
Massey, V.,
and Hemmerich, P.
(1980)
Biochem. Soc. Trans.
8,
246-257[Medline]
[Order article via Infotrieve]
-
Ghisla, S.,
and Massey, V.
(1986)
Biochem. J.
239,
1-12[Medline]
[Order article via Infotrieve]
-
Walsh, C. T.,
Schonbrunn, A.,
and Abeles, R. H.
(1971)
J. Biol. Chem.
246,
6855-6866[Abstract/Free Full Text]
-
Ghisla, S.,
and Massey, V.
(1989)
Eur. J. Biochem.
181,
1-17[Medline]
[Order article via Infotrieve]
-
Edgar, J. R.,
and Bell, R. M.
(1978)
J. Biol. Chem.
253,
6354-6363[Abstract/Free Full Text]
-
Bright, H. J.,
and Gibson, Q. H.
(1967)
J. Biol. Chem.
242,
994-1003[Abstract/Free Full Text]
-
Bright, H. J.,
and Appleby, M.
(1969)
J. Biol. Chem.
244,
3625-3634[Abstract/Free Full Text]
-
Weibel, M. K.,
and Bright, H. J.
(1971)
J. Biol. Chem.
246,
2734-2744[Abstract/Free Full Text]
-
Li, J.,
Vrielink, A.,
Brick, P.,
and Blow, D. M.
(1993)
Biochemistry
32,
11507-11515[CrossRef][Medline]
[Order article via Infotrieve]
-
Vrielink, A.,
Li, J.,
Brick, P.,
and Blow, D.
(1994)
in
Flavins and Flavoproteins 1993 (Yagi, K., ed), pp. 175-184, Walter de Gruyter, New York
-
Parsonage, D.,
Miller, H.,
Ross, R. P.,
and Claiborne, A.
(1993)
J. Biol. Chem.
268,
3161-3167[Abstract/Free Full Text]
-
Parsonage, D.,
and Claiborne, A.
(1995)
Biochemistry
34,
435-441[CrossRef][Medline]
[Order article via Infotrieve]
-
Charrier, V.,
Buckley, E.,
Parsonage, D.,
Galinier, A.,
Darbon, E.,
Jaquinod, M.,
Forest, E.,
Deutscher, J.,
and Claiborne, A.
(1997)
J. Biol. Chem.
272,
14166-14174[Abstract/Free Full Text]
-
Nakamura, Y.,
Wada, K.,
Wada, Y.,
Doi, H.,
Kanaya, S.,
Gojobori, T.,
and Ikemura, T.
(1996)
Nucleic Acids Res.
24,
214-215[Abstract/Free Full Text]
-
Pearce, B. J.,
Yin, Y. B.,
and Masure, H. R.
(1993)
Mol. Microbiol.
9,
1037-1050[Medline]
[Order article via Infotrieve]
-
Saluja, S. K.,
and Weiser, J. N.
(1995)
Mol. Microbiol.
16,
215-227[CrossRef][Medline]
[Order article via Infotrieve]
-
Caparon, M. G.,
and Scott, J. R.
(1991)
Methods Enzymol.
204,
556-586[Medline]
[Order article via Infotrieve]
-
Strathman, M.,
Hamilton, B. A.,
Mayeda, C. A.,
Simon, M. I.,
Meyerowitz, E. M.,
and Palazzolo, M. J.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
1247-1250[Abstract/Free Full Text]
-
Devereux, J.,
Haeberli, P.,
and Smithies, O.
(1984)
Nucleic Acids Res.
12,
387-395
-
Studier, F. W.,
Rosenberg, A. H.,
Dunn, J. J.,
and Dubendorff, J. W.
(1990)
Methods Enzymol.
185,
60-89[Medline]
[Order article via Infotrieve]
-
Loach, P. A.
(1976)
in
Handbook of Biochemistry and Molecular Biology (Fasman, G. D., ed), 3rd Ed., Vol. I, pp. 122-130, CRC Press, Boca Raton, FL
-
Mallett, T. C.,
and Claiborne, A.
(1998)
Biochemistry
37,
8790-8802[CrossRef][Medline]
[Order article via Infotrieve]
-
Gibson, Q. H.,
Swoboda, B. E. P.,
and Massey, V.
(1964)
J. Biol. Chem.
239,
3927-3934[Free Full Text]
-
Harris, C. M.,
and Massey, V.
(1997)
J. Biol. Chem.
272,
8370-8379[Abstract/Free Full Text]
-
Cornish-Bowden, A.
(1995)
Fundamentals of Enzyme Kinetics, Portland Press, London
-
Crane, E. J., III,
Parsonage, D.,
Poole, L. B.,
and Claiborne, A.
(1995)
Biochemistry
34,
14114-14124[CrossRef][Medline]
[Order article via Infotrieve]
-
Bull, C.,
and Ballou, D. P.
(1981)
J. Biol. Chem.
256,
12673-12680[Abstract/Free Full Text]
-
Frederick, K. R.,
Tung, J.,
Emerick, R. S.,
Masiarz, F. R.,
Chamberlain, S. H.,
Vasavada, A.,
Rosenberg, S.,
Chakraborty, S.,
Schopfer, L. M.,
and Massey, V.
(1990)
J. Biol. Chem.
265,
3793-3802[Abstract/Free Full Text]
-
Holmberg, C.,
Beijer, L.,
Rutberg, B.,
and Rutberg, L.
(1990)
J. Gen. Microbiol.
136,
2367-2375[Abstract/Free Full Text]
-
Austin, D.,
and Larson, T. J.
(1991)
J. Bacteriol.
173,
101-107[Abstract/Free Full Text]
-
Schweizer, H.,
and Po, C.
(1994)
J. Bacteriol.
176,
2184-2193[Abstract/Free Full Text]
-
Higgins, D. G.,
and Sharp, P. M.
(1988)
Gene (Amst.)
73,
237-244[CrossRef][Medline]
[Order article via Infotrieve]
-
Wierenga, R. K.,
Terpstra, P.,
and Hol, W. G. J.
(1986)
J. Mol. Biol.
187,
101-107[CrossRef][Medline]
[Order article via Infotrieve]
-
SWISS-PROT, Accession number P32191
-
Brown, L. J.,
MacDonald, M. J.,
Lehn, D. A.,
and Moran, S. M.
(1994)
J. Biol. Chem.
269,
14363-14366[Abstract/Free Full Text]
-
Lehn, D. A.,
Brown, L. J.,
Simonson, G. D.,
Moran, S. M.,
and MacDonald, M. J.
(1994)
Gene (Amst.)
150,
417-418[CrossRef][Medline]
[Order article via Infotrieve]
-
Roe, B. A., Clifton, S., McShan, M., and Ferretti, J. (1998)
Streptococcal Genome Sequencing Project,
http://dna1.chem.uoknor.edu/strep.html
-
Erlandson, K.,
and Batt, C. A.
(1997)
Appl. Environ. Microbiol.
63,
2702-2707[Abstract]
-
Massey, V.,
Müller, F.,
Feldberg, R.,
Schuman, M.,
Sullivan, P. A.,
Howell, L. G.,
Mayhew, S. G.,
Matthews, R. G.,
and Foust, G. P.
(1969)
J. Biol. Chem.
244,
3999-4006[Abstract/Free Full Text]
-
Gadda, G.,
Wels, G.,
Pollegioni, L.,
Zucchelli, S.,
Ambrosius, D.,
Pilone, M. S.,
and Ghisla, S.
(1997)
Eur. J. Biochem.
250,
369-376[Medline]
[Order article via Infotrieve]
-
Massey, V.
(1995)
FASEB J.
9,
473-475[Medline]
[Order article via Infotrieve]
-
Massey, V.,
Matthews, R. G.,
Foust, G. P.,
Howell, L. G.,
Williams, C. H., Jr.,
Zanetti, G.,
and Ronchi, S.
(1969)
in
Pyridine Nucleotide-Dependent Dehydrogenases (Sund, H., ed), pp. 393-411, Springer-Verlag, Berlin
-
Stankovich, M.,
and Fox, B.
(1983)
Biochemistry
22,
4466-4472[CrossRef][Medline]
[Order article via Infotrieve]
-
Massey, V.
(1991)
in
Flavins and Flavoproteins 1990 (Curti, B., Ronchi, S., and Zanetti, G., eds), pp. 59-66, Walter de Gruyter, New York
-
Gutfreund, H.
(1972)
Enzymes: Physical Principles, John Wiley and Sons, New York
-
Strickland, S.,
Palmer, G.,
and Massey, V.
(1975)
J. Biol. Chem.
250,
4048-4052[Free Full Text]
-
Lin, E. C. C.
(1996)
in
Escherichia coli and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C., Curtiss, R., III, Ingraham, J. L., Lin, E. C. C., Low, K. B., Magasanik, B., Reznikoff, W. S., Riley, M., Schaechter, M., and Umbarger, H. E., eds), 2nd Ed., Vol. 1, pp. 217-261, American Society for Microbiology, Washington, D.C.
-
Jacobs, N. J.,
and VanDemark, P. J.
(1960)
Arch. Biochem. Biophys.
88,
250-255[CrossRef][Medline]
[Order article via Infotrieve]
-
Hatefi, Y.,
and Stiggall, D. L.
(1976)
in
The Enzymes (Boyer, P. D., ed), 3rd Ed., Vol. 13, pp. 175-297, Academic Press, New York
-
Hardie, J. M.
(1986)
in
Bergey's Manual of Systematic Bacteriology (Sneath, P. H. A., ed), Vol. 2, pp. 1043-1071, Williams & Wilkins, Baltimore
-
Schryvers, A.,
Lohmeier, E.,
and Weiner, J. H.
(1978)
J. Biol. Chem.
253,
783-788[Abstract/Free Full Text]
-
Garrib, A.,
and McMurray, W. C.
(1986)
J. Biol. Chem.
261,
8042-8048[Abstract/Free Full Text]
-
Mitra, B.,
Gerlt, J. A.,
Babbitt, P. C.,
Koo, C. W.,
Kenyon, G. L.,
Joseph, D.,
and Petsko, G. A.
(1993)
Biochemistry
32,
12959-12967[CrossRef][Medline]
[Order article via Infotrieve]
-
Stankovich, M. T.,
Schopfer, L. M.,
and Massey, V.
(1978)
J. Biol. Chem.
253,
4971-4979[Abstract/Free Full Text]
-
Müller, F.,
and Massey, V.
(1969)
J. Biol. Chem.
244,
4007-4016[Abstract/Free Full Text]
-
Todone, F.,
Vanoni, M. A.,
Mozzarelli, A.,
Bolognesi, M.,
Coda, A.,
Curti, B.,
and Mattevi, A.
(1997)
Biochemistry
36,
5853-5860[CrossRef][Medline]
[Order article via Infotrieve]
-
Pollegioni, L.,
Blodig, W.,
and Ghisla, S.
(1997)
J. Biol. Chem.
272,
4924-4934[Abstract/Free Full Text]
-
Yorita, K.,
Janko, K.,
Aki, K.,
Ghisla, S.,
Palfey, B. A.,
and Massey, V.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9590-9595[Abstract/Free Full Text]
-
Mattevi, A.,
Vanoni, M. A.,
and Curti, B.
(1997)
Curr. Op. Struct. Biol.
7,
804-810[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. I. Yeh, U. Chinte, and S. Du
Structure of glycerol-3-phosphate dehydrogenase, an essential monotopic membrane enzyme involved in respiration and metabolism
PNAS,
March 4, 2008;
105(9):
3280 - 3285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Gibson, T. C. Mallett, A. Claiborne, and M. G. Caparon
Contribution of NADH Oxidase to Aerobic Metabolism of Streptococcus pyogenes
J. Bacteriol.,
January 15, 2000;
182(2):
448 - 455.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. W. Fraaije, R. H. H. van den Heuvel, W. J. H. van Berkel, and A. Mattevi
Covalent Flavinylation Is Essential for Efficient Redox Catalysis in Vanillyl-alcohol Oxidase
J. Biol. Chem.,
December 10, 1999;
274(50):
35514 - 35520.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|